GundersenAIR Pioneers Adoption of OneDose Technology for Enhanced Flight Operations
June 26, 2025 - 21:13
GundersenAIR has made a significant advancement by incorporating Hinckley Medical’s OneDose system into its operations. This strategic move marks GundersenAIR as the first flight emergency medical service (EMS) to adopt this innovative technology, which is designed to streamline workflows and enhance the efficiency of medical operations in the air.
The OneDose system offers a range of benefits, including improved medication management and reduced risk of errors during critical situations. By integrating this technology, GundersenAIR aims to bolster its commitment to providing high-quality patient care while ensuring that its medical teams are equipped with the best tools available.
This adoption not only signifies a leap forward in emergency medical services but also sets a precedent for other flight EMS organizations. As the healthcare landscape continues to evolve, GundersenAIR's proactive approach highlights the importance of embracing technological advancements to improve patient outcomes and operational effectiveness in the field.
MORE NEWS
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...